Several evidence underline the concept that PTX3 might function as modulator of inflammatory processes in patients with autoimmune disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis and systemic vasculitis and the PTX3 concentration increases in correlation with disease activity (15-20). This evidence concerns the gene PTX3 and necrotizing vasculitis.